Product Information
RISPERIDONE ER 50 MG VIAL is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $812.3827 per EA under NDC 70748027213. Its NADAC has been published 25 times since Jan 7, 2026.
The High Outlier badge above means this manufacturer's average price in the risperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
70748027213
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA211220On Market Since
10/17/2025
Price Statistics
The NADAC for RISPERIDONE ER 50 MG VIAL has been published 25 times since Jan 7, 2026, and over the history we have for it it has declined 14.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $812.3827 per EA |
|---|---|
| All-time high | $948.7572 (Jan 14, 2026) |
| All-time low | $812.3827 (Jun 17, 2026) |
| 52-week high | $948.7572 |
| 52-week low | $812.3827 |
| Median price | $927.2114 |
| Average price | $908.8476 |
| Largest weekly change | -6.2% (Jun 17, 2026) |
| Weeks tracked | 25 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 61% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RISPERIDONE ER 50 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for RISPERIDONE ER 50 MG VIAL, manufactured by Lupin Pharmaceuticals Inc., is $812.3827 per EA (NDC 70748027213), effective Jun 24, 2026.
How has the price of RISPERIDONE ER 50 MG VIAL changed over time?
Over the history we have for it, the NADAC for RISPERIDONE ER 50 MG VIAL has declined 14.4%. It has been tracked across 25 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for RISPERIDONE ER 50 MG VIAL?
Since Jan 7, 2026, the NADAC for RISPERIDONE ER 50 MG VIAL has ranged from a low of $812.3827 (Jun 17, 2026) to a high of $948.7572 (Jan 14, 2026), with a median of $927.2114 per EA.
Are there cheaper alternatives to RISPERIDONE ER 50 MG VIAL?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RISPERDAL CONSTA 12.5 MG VIAL, is $318.0511 per EA — about 61% below RISPERIDONE ER 50 MG VIAL.
Who manufactures RISPERIDONE ER 50 MG VIAL?
RISPERIDONE ER 50 MG VIAL (NDC 70748027213) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification